HAILEY FARMER: Open Payments
NPI 1003383746 · HUNTSVILLE, AL. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$3,064 in 138 payments from 20 companies in 2025. Trend: 2023 $263 · 2024 $894 · 2025 $3,064
Food & beverage: $3,005Education: $59
| Company | Payments | Amount |
|---|---|---|
| AstraZeneca Pharmaceuticals LP | 22 | $621 |
| Regeneron Healthcare Solutions, Inc. | 19 | $419 |
| ARS Pharmaceuticals Operations, Inc. | 17 | $328 |
| CSL Behring | 14 | $323 |
| Novartis Pharmaceuticals Corporation | 12 | $238 |
| GENZYME CORPORATION | 7 | $186 |
| GlaxoSmithKline, LLC. | 9 | $185 |
| Amgen Inc. | 9 | $182 |
| Blueprint Medicines Corporation | 4 | $101 |
| Genentech USA, Inc. | 6 | $100 |
Products named: DUPIXENT, TEZSPIRE, NEFFY, Hizentra, Xolair, AYVAKIT, Rhapsido, NUCALA.
Industry payments across AL — which companies pay providers there.
